Table 1.

Summary of the clinicopathological features, FGFR1 and NCAM expression in RCC

Case no.	Age	Sex	Tumor size (cm)#	Nuclear Grade	Stage	FGFR1	NCAM	FGFR1/NCAM coexpression
Clear cell RCC
1	61	F	6	1	pT2NxMx	+	-	no
2	39	M	3.5	1	pT2NxMx	+	+	yes
3	58	M	4	1	pT1aNxMx	+	+	yes
4	87	F	2.5	1	pT3aNxMx	-	-	no
5	71	M	5.5	1	pT3aNxMx	+	+	yes
6	54	M	10	2	pT3bNoMx	+	+	yes
7	64	M	9	2	pT3aNxMx	+	+	yes
8	46	F	12	2	pT3aNxMx	-	-	no
9	58	M	6	3	pT1bNxMx	+	+	yes
10	74	F	5	3	pT3aNxMx	+	+	yes
11	44	M	7	3	pT1bNxMx	+	+	yes
12	36	M	9	3	pT4N2M1	+	-	no
13	60	F	13.5	4	pT3aNoMx	+	+	yes
14	75	F	8	4	pT3aNxMx	+	+	yes
15	57	F	8	4	pT3N2Mx	+	+	yes
16	64	M	8	4	pT3aNxMx	+	+	yes
Multilocular cystic RCC
1	47	M	4	1	pT1aNxMx	-	-	no
2	34	M	4.5	1	pT1bNxMx	-	-	no
3	44	F	6	2	pT1bNxMx	+	+	yes
Papillary RCC
1	62	M	4.2	1, type I	pT3aNxMx	+	+	yes
2	59	M	3	1, type II	pT3aNxMx	+	+	yes
3	59	M	6	1, type II	pT3NxMx	-	-	no
4	55	M	4.5	2, type II	pT1bNxMx	+	+	yes
5	59	M	3.5	2, type II	pT1aNxMx	+	+	yes
6	47	M	4	2, type II	pT1aNxMx	-	-	no
7	59	M	3.5	2, type II	pT1aNxMx	+	+	yes
8	50	M	1.5	2, type II	pT1aNxMx	+	+	yes
9	55	M	4.5	3, type II	pT3aNxMx	+	+	yes
10	65	M	NK	3, type I	pT3bNxMx	+	+	yes
11	56	M	10	3, type II	pT3aNxMx	+	+	yes
12	48	M	12	4, type II	pT3aNxMx	+	+	yes
Chromophobe RCC
1	43	M	NK	1	NK	+	-	no
2	39	F	5	2	pT1bNxMx	+	-	no
3	60	M	2	2	pT1aNxMx	+	+	yes
4	70	F	1.5	2	pT1aNxMx	+	+	yes
5	61	M	7	2	pT1bNxMx	+	+	yes

^#the biggest tumor diameter, RCC - renal cell carcinoma, FGFR1 - fibroblast growth factor receptor 1, NCAM - neural cell adhesion molecule, NK - not known.